Massive Discount Recombinant Human Pin1/rotamase Pin1 Protein - Don't Overpay [FL9nvlyO]

Massive Discount Recombinant Human Pin1/rotamase Pin1 Protein - Don't Overpay [FL9nvlyO]: A Cutting-Edge Research Tool

Discover the power of our Massive Discount Recombinant Human Pin1/rotamase Pin1 Protein - Don't Overpay [FL9nvlyO], a highly purified and active recombinant protein designed for advanced research in cell biology and molecular biology. This protein is a crucial tool for understanding the complex mechanisms of protein folding, stability, and signaling in cells. Its recombinant nature ensures high purity and reproducibility, making it ideal for various experimental applications.

Key Features and Specifications

Our PIN1 protein is expressed in E. coli and offers a seamless integration into your research workflow. It is isolated with a purity of >95% as determined by reducing SDS-PAGE, ensuring the highest level of accuracy and reliability. With a calculated molecular weight of 18.2 kDa and an observed molecular weight of 18 kDa, this protein is ready for use in various applications. Additionally, it is tagged with none, allowing for maximum flexibility in your experiments.

• High purity recombinant protein
• Expressed in E. coli
• No tag for flexibility in experimentation

Applications and Benefits

Our Massive Discount Recombinant Human Pin1/rotamase Pin1 Protein - Don't Overpay [FL9nvlyO] is a valuable resource for researchers studying cell cycle progression, protein folding, and oncogenic pathways. Its involvement in regulating cell cycle progression, particularly in the context of breast cancer, makes it an essential tool for exploring new therapeutic targets. This protein is suitable for use in various applications, including ELISA, western blot, immunoprecipitation, and more. By using our PIN1 protein, you can gain deeper insights into the complex interactions that govern cellular processes, leading to groundbreaking discoveries and advancements in the field of biology.

• Essential for research on cell cycle progression and oncogenic pathways
• Valuable for exploring new therapeutic targets in breast cancer